Experimental virus-antibody combo for tough skin cancer shows early promise but study stopped
NCT ID NCT04163952
First seen Jan 30, 2026 · Last updated May 01, 2026 · Updated 12 times
Summary
This early-phase trial tested a combination of two treatments for advanced skin squamous cell carcinoma: a modified virus that helps the immune system attack tumors (talimogene laherparepvec) and an antibody that blocks cancer growth signals (panitumumab). The study enrolled 5 adults whose cancer had spread or come back. The main goals were to check safety and see how well the combo worked. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SKIN SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center - Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, 10016, United States
-
NYU Langone Medical Center (Tisch Hospital)
New York, New York, 10016, United States
-
New York University Langone Medical Center
New York, New York, 10016, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
Conditions
Explore the condition pages connected to this study.